The Cancer Screening Committee
- deals with questions surrounding population-based cancer screenings
- independently assesses scientific evidence and observes developments in Switzerland and abroad
- considers medical indications, epidemiological, economic, legal and ethical aspects, as well as the interests of patients
- formulates recommendations for cancer screening measures
Composition of the Committee of Experts
| Epidemiology, Methodology, Statistics | Prof. Dr. Marcel Zwahlen, Institute for Social and Preventive Medicine, University of Bern, Chairman of the Cancer Screening Committee Prof. Dr. med. Thomas Agoritsas, Divisions of Internal Medicine & Clinical Epidemiology, Geneva University Hospitals |
| Medicine (Clinical Everyday Life and Prevention) | Prof. Dr. med. Stefan Aebi, Chief physician of medical oncology and Chair of the Tumor Center, Lucerne Cantonal Hospital Prof. Dr. med. Reto Auer, Bern Institute for Family Medicine (BIHAM), University of Bern, Centre universitaire de médecine générale et santé publique, Université de Lausanne Dr. med. Reto Guetg, Medical Officer santésuisse, Bern |
| Screening | Dr. med. Jacques Fracheboud, Erasmus University Medical Center, Rotterdam (NL) |
| Economics | Prof. Dr. Matthias Schwenkglenks, Institute of Pharmaceutical Medicine, University of Basel, Institute of Epidemiology, Biostatistics and Prevention, University of Zurich |
| Ethics | Prof. Dr med. Samia Hurst-Majno, Institut éthique histoire humanités, Université de Genève |
| Law | lic. iur. Michelle Salathé, Medicine Ethics Law, Basel |
| Representative of Patients | David U. Haerry, Chairman Positive Council, European Patients Academy (EUPATI), Zurich |